基本信息
浏览量:150
职业迁徙
个人简介
Professor Schuh has participated as a principal or chief investigator in over 30 early or late phase clinical trials in chronic lymphocytic leukaemia.
A number of these led to NICE approvals and have changed clinical practice for patients in the UK and worldwide. As a result, she was recently appointed as the Chair of Chronic Lymphocytic Leukaemia Research in the UK by the National Cancer Research Institute. In addition to other national and international roles, she has also chaired the UK CLL Forum from 2016 to 2019 that promotes training and education, and she led the UK's guidelines writing group for CLL Therapy on behalf of the British Society of Haematology.
Her life-long research interest has been with the development, evaluation and implementation of new technologies for Precision Diagnostics in particular genomics. Her group published the first ever longitudinal study of the changes in the genomic landscape of patients undergoing treatment for leukaemia. More recently, her group has been focussing on identifying novel biomarkers for early detection of B-cell malignancies from liquid biopsies.
He group has developed and clinically validated a method for non-invasive prenatal diagnosis of autosomal recessive disorders using haemoglobinopathies as a model.
She was appointed as the Director of Molecular Diagnostics by the University of Oxford in 2014. She served as the Clinical Lead for the Oxford Genomics Medicine Centre from 2014 to 2017 and has led the Genomics England Clinical Interpretation Partnership for haematological malignancies.
She is also the Co-director of the University's online part-time Master's Programme in Precision Cancer Medicine.
Professor Schuh has received grants from the NIHR, Wellcome Trust, Technology Strategy Board (now Innovate UK), Cancer Research UK and Bloodwise and she has authored or co-authored over 80 peer-reviewed publications in the last five years.
A number of these led to NICE approvals and have changed clinical practice for patients in the UK and worldwide. As a result, she was recently appointed as the Chair of Chronic Lymphocytic Leukaemia Research in the UK by the National Cancer Research Institute. In addition to other national and international roles, she has also chaired the UK CLL Forum from 2016 to 2019 that promotes training and education, and she led the UK's guidelines writing group for CLL Therapy on behalf of the British Society of Haematology.
Her life-long research interest has been with the development, evaluation and implementation of new technologies for Precision Diagnostics in particular genomics. Her group published the first ever longitudinal study of the changes in the genomic landscape of patients undergoing treatment for leukaemia. More recently, her group has been focussing on identifying novel biomarkers for early detection of B-cell malignancies from liquid biopsies.
He group has developed and clinically validated a method for non-invasive prenatal diagnosis of autosomal recessive disorders using haemoglobinopathies as a model.
She was appointed as the Director of Molecular Diagnostics by the University of Oxford in 2014. She served as the Clinical Lead for the Oxford Genomics Medicine Centre from 2014 to 2017 and has led the Genomics England Clinical Interpretation Partnership for haematological malignancies.
She is also the Co-director of the University's online part-time Master's Programme in Precision Cancer Medicine.
Professor Schuh has received grants from the NIHR, Wellcome Trust, Technology Strategy Board (now Innovate UK), Cancer Research UK and Bloodwise and she has authored or co-authored over 80 peer-reviewed publications in the last five years.
研究兴趣
论文共 354 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
LEUKEMIA & LYMPHOMAno. 4 (2024): 413-429
Rocio Figueroa-Mora,Alexandros Rampotas, Daniel Halperin, Tina Worth,Jennifer Vidler,Dario Melotti, Paul Ferguson,Nagah Elmusharaf,Gavin Preston,Michelle Furtado,Moez Dungarwalla,Satyen Gohill,
Dimitris Vavoulis,Anthony Cutts, Nishita Thota, Jordan Brown, Robert Sugar, Antonio Rueda, Arman Ardalan, Flavia Matos Santo, Thippesh Sannasiddappa, Bronwen Miller,Stephen Ash, Yibin Liu,
medRxiv (Cold Spring Harbor Laboratory) (2023)
引用0浏览0引用
0
0
JOURNAL OF CLINICAL ONCOLOGYno. 15 (2023): 2718-+
The Lancet Oncologyno. 5 (2023): 535-552
引用3浏览0WOS引用
3
0
引用0浏览0引用
0
0
HemaSphereno. S3 (2023): e96103aa-e96103aa
引用0浏览0引用
0
0
Journal of Pathology Informatics (2023): 100188-100188
Rocio Figueroa-Mora,Alexandros Rampotas, Daniel M. Halperin, Tina Worth,Jennifer Vidler,Dario Melotti, Paul Ferguson,Nagah Elmusharaf,Gavin Preston,Michelle Furtado,Moez Dungarwalla,Satyen Gohil,
British Journal of Haematologyno. 1 (2023): 48-53
引用0浏览0引用
0
0
Peter Hillmen,Alexandra Pitchford,Adrian Bloor, Angus Broom,Moya Young,Ben Kennedy,Renata Walewska,Michelle Furtado,Gavin Preston, Jeffrey R. Neilson,Nicholas Pemberton,Gamal Sidra,
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn